In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

President Joe Biden’s proposal to have GLP-1 weight-loss drugs such as Ozempic and Mounjaro covered by Medicare and Medicaid ...

President Joe Biden is trying to expand access to pricey blockbuster drugs in his final months in office. The Biden-Harris ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

“I love Thanksgiving for the pumpkin pie — it's such a low-sugar dessert that it tends to be fine for your blood sugar,” ...

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...